Patents Assigned to Pharmasurgics in Sweden AB
  • HUMAN LACTOFERRIN DERIVED PEPTIDES AND THEIR USE
    Publication number: 20130310306
    Abstract: The present invention relates to new peptides and to use thereof, in particular for treatment and/or prevention of infections, inflammations, pain, wounds, scar and/or tumours.
    Type: Application
    Filed: January 25, 2012
    Publication date: November 21, 2013
    Applicant: PharmaSurgics In Sweden AB
    Inventors: Margit Mahlapuu, Camilla Bjöm, Veronika Sjöstrand, Bjöm Walse, Bo Svenson
  • SYNTHETIC ARGININE SUBSTITUTED PEPTIDES AND THEIR USE
    Publication number: 20110224152
    Abstract: The present invention relates to new arginine substituted peptides designed based on the sequence of human lactoferrin and to use thereof, in particular for treatment and/or prevention of infections, inflammations, tumours, pain, wounds and/or scars.
    Type: Application
    Filed: April 19, 2011
    Publication date: September 15, 2011
    Applicant: PHARMASURGICS IN SWEDEN AB
    Inventors: INGER MATTSBY-BALTZER, GUNNAR DOLPHIN
  • Methods for reduction of adhesion formation using cytokine inhibitors
    Patent number: 7994116
    Abstract: The present invention relates to a method for prevention or reduction of scar tissue and/or adhesion formation wherein a therapeutically effective amount of a substance that inhibits a pro-inflammatory cytokine is administered to a patient in need of said treatment.
    Type: Grant
    Filed: August 14, 2008
    Date of Patent: August 9, 2011
    Assignee: Pharmasurgics In Sweden AB
    Inventor: Kjell Olmarker
  • Synthetic arginine substituted peptides and their use
    Patent number: 7928185
    Abstract: The present invention relates to new arginine substituted peptides designed based on the sequence of human lactoferrin and to use thereof, in particular for treatment and/or prevention of infections, inflammations, tumours, pain, wounds and/or scars.
    Type: Grant
    Filed: November 10, 2008
    Date of Patent: April 19, 2011
    Assignee: PharmaSurgics in Sweden AB
    Inventors: Inger Mattsby-Baltzer, Gunnar Dolphin
  • NOVEL USE OF CYTOKINE INHIBITORS
    Publication number: 20100305048
    Abstract: The use of substance that inhibits a pro-inflammatory cytokine, such as TNF or IL-1, for the production of a pharmaceutical composition for improving wound healing is disclosed. Also, a method for improving wound healing wherein a therapeutically effective amount of a substance that inhibits a pro-inflammatory cytokine is administered to a patient in need of said treatment is disclosed.
    Type: Application
    Filed: March 3, 2010
    Publication date: December 2, 2010
    Applicant: PHARMASURGICS IN SWEDEN AB
    Inventor: Kjell OLMARKER
  • Peptides based on the sequence of human lactoferrin and their use
    Patent number: 7803757
    Abstract: The invention relates to new peptides formed of at least seven subsequent amino acids of the amino acids in position 12-40, counted from the N-terminal end, in the sequence constituting human lactoferrin, and preferably modifications thereof. The invention also relates to medicinal products comprising such peptides, especially intended for treatment and prevention of infections, inflammations and tumours. Furthermore, the invention relates to food stuff, e.g. infant formula food, comprising the above mentioned peptides.
    Type: Grant
    Filed: June 29, 2007
    Date of Patent: September 28, 2010
    Assignee: PharmaSurgics in Sweden AB
    Inventors: Lars A. Hanson, Lars Baltzer, Inger Mattsby-Baltzer, Gunnar T. Dolphin
  • Synthetic arginine substituted peptides and their use
    Publication number: 20090186823
    Abstract: The present invention relates to new arginine substituted peptides designed based on the sequence of human lactoferrin and to use thereof, in particular for treatment and/or prevention of infections, inflammations, tumours, pain, wounds and/or scars.
    Type: Application
    Filed: November 10, 2008
    Publication date: July 23, 2009
    Applicant: PharmaSurgics in Sweden AB
    Inventors: Inger Mattsby-Baltzer, Gunnar Dolphin
  • NOVEL USE OF CYTOKINE INHIBITORS
    Publication number: 20090149379
    Abstract: The present invention relates to a method for prevention or reduction of scar tissue and/or adhesion formation wherein a therapeutically effective amount of a substance that inhibits a pro-inflammatory cytokine is administered to a patient in need of said treatment.
    Type: Application
    Filed: August 14, 2008
    Publication date: June 11, 2009
    Applicant: PHARMASURGICS IN SWEDEN AB
    Inventor: Kjell OLMARKER
  • Peptides based on the sequence of human lactoferrin and their use
    Publication number: 20080299180
    Abstract: The invention relates to new peptides formed of at least seven subsequent amino acids of the amino acids in position 12-40, counted from the N-terminal end, in the sequence constituting human lactoferrin, and preferably modifications thereof. The invention also relates to medicinal products comprising such peptides, especially intended for treatment and prevention of infections, inflammations and tumours. Furthermore, the invention relates to food stuff, e.g. infant formula food, comprising the above mentioned peptides.
    Type: Application
    Filed: June 29, 2007
    Publication date: December 4, 2008
    Applicant: PharmaSurgics in Sweden AB
    Inventors: Lars A. Hanson, Lars Baltzer, Inger Mattsby-Baltzer, Gunnar T. Dolphin
  • Use of cytokine inhibitors
    Patent number: 7427589
    Abstract: The present invention relates to a method for prevention or reduction of scar tissue and/or adhesion formation wherein a therapeutically effective amount of a substance that inhibits a pro-inflammatory cytokine such as TNF or IL-1, is administered to a patient in need of said treatment.
    Type: Grant
    Filed: March 8, 2002
    Date of Patent: September 23, 2008
    Assignee: Pharmasurgics in Sweden AB
    Inventor: Kjell Olmarker
  • Peptides based on the sequence of human lactoferrin and their use
    Patent number: 7253143
    Abstract: The invention relates to new peptides formed of at least seven subsequent amino acids of the amino acids in position 12-40, counted from the N-terminal end, in the sequence constituting human lactoferrin, and preferably modifications thereof. The invention also relates to medicinal products comprising such peptides, especially intended for treatment and prevention of infections, inflammations and tumours. Furthermore, the invention relates to food stuff, e.g. infant formula food, comprising the above mentioned peptides.
    Type: Grant
    Filed: July 6, 1999
    Date of Patent: August 7, 2007
    Assignee: Pharmasurgics in Sweden AB
    Inventors: Lars {dot over (A)}. Hanson, Lars Baltzer, Inger Mattsby-Baltzer, Gunnar T. Dolphin